Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03513952
Title Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Kaiser Permanente-Riverside Riverside California 92505 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Straub Clinic and Hospital Honolulu Hawaii 96813 United States Details
University of Hawaii Cancer Center Honolulu Hawaii 96813 United States Details
University of Chicago Comprehensive Cancer Center Chicago Illinois 60637 United States Details
East Jefferson General Hospital Metairie Louisiana 70006 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
FHCC South Lake Union Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field